recall
saveSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls II)
community read0 votes
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7 — Reason: Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%. — Status: Ongoing
view source ↗Data sources
last refreshed 29m ago
Found something off?
same company · ±60 days · 6
- approvalZYPREXA (OLANZAPINE) — FDA approvalJan 30, 2026
- approvalZYPREXA (OLANZAPINE) — FDA approvalJan 30, 2026
- approvalOLANZAPINE — FDA approvalJan 23, 2026
- recallSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)Jan 21, 2026
- recallSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)Jan 21, 2026
- approvalOLANZAPINE — FDA approvalMar 5, 2026
comments(0)
5-min edit window · permanent after that